Ameritas Investment Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-865
| Closed | -$12.8K | – | 3306 |
|
|
2024
Q1 | $12.8K | Hold |
865
| – | – | ﹤0.01% | 2750 |
|
|
2023
Q4 | $11.6K | Hold |
865
| – | – | ﹤0.01% | 2801 |
|
|
2023
Q3 | $10.7K | Hold |
865
| – | – | ﹤0.01% | 2821 |
|
|
2023
Q2 | $10.6K | Buy |
+865
| New | +$10.6K | ﹤0.01% | 2894 |
|
|
2018
Q2 | – | Sell |
-1,338
| Closed | -$8K | – | 3156 |
|
|
2018
Q1 | $8K | Hold |
1,338
| – | – | ﹤0.01% | 2804 |
|
|
2017
Q4 | $11K | Sell |
1,338
-12,057
| -90% | -$99.1K | ﹤0.01% | 2737 |
|
|
2017
Q3 | $14K | Buy |
13,395
+12,055
| +900% | +$12.6K | ﹤0.01% | 2638 |
|
|
2017
Q2 | $13K | Hold |
1,340
| – | – | ﹤0.01% | 2733 |
|
|
2017
Q1 | $32K | Hold |
1,340
| – | – | ﹤0.01% | 2133 |
|
|
2016
Q4 | $43K | Hold |
1,340
| – | – | ﹤0.01% | 1126 |
|
|
2016
Q3 | $67K | Buy |
+1,340
| New | +$67K | ﹤0.01% | 1089 |
|